Get the Stockscreener App
3.87
1.78%
-0.07
After Hours:
3.93
0.06
+1.55%
Larimar Therapeutics Inc stock is traded at $3.87, with a volume of 1.02M.
It is down -1.78% in the last 24 hours and up +16.92% over the past month.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
See More
Previous Close:
$3.94
Open:
$3.94
24h Volume:
1.02M
Relative Volume:
0.75
Market Cap:
$331.23M
Revenue:
-
Net Income/Loss:
$-36.95M
P/E Ratio:
-4.6071
EPS:
-0.84
Net Cash Flow:
$-33.46M
1W Performance:
-1.02%
1M Performance:
+16.92%
6M Performance:
+38.71%
1Y Performance:
-50.19%
1-Day Range:
$3.75
$3.95
1-Week Range:
$3.59
$4.05
52-Week Range:
$1.61
$9.50
Larimar Therapeutics Inc Stock (LRMR) Company Profile
Name
Larimar Therapeutics Inc
Sector
Industry
Phone
844-511-9056
Address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
Compare LRMR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
3.87 | 317.54M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Initiated | Truist | Buy |
| Oct-16-24 | Initiated | Oppenheimer | Outperform |
| Oct-03-24 | Initiated | Wedbush | Outperform |
| Oct-02-24 | Initiated | H.C. Wainwright | Buy |
| Sep-04-24 | Initiated | Robert W. Baird | Outperform |
| Apr-03-24 | Initiated | Leerink Partners | Outperform |
| Nov-17-23 | Upgrade | Citigroup | Neutral → Buy |
| Oct-19-22 | Initiated | Guggenheim | Buy |
| Feb-15-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-10-21 | Initiated | JMP Securities | Mkt Outperform |
| Feb-01-21 | Initiated | William Blair | Outperform |
View All
Larimar Therapeutics Inc Stock (LRMR) Latest News
Smart tools for monitoring Larimar Therapeutics Inc.’s price actionLong Setup & Risk Adjusted Swing Trade Ideas - Newser
Can Larimar Therapeutics Inc. expand its profit marginsOil Prices & Daily Stock Trend Watchlist - khodrobank.com
How to integrate Larimar Therapeutics Inc. into portfolio analysis toolsTrade Volume Report & Scalable Portfolio Growth Methods - Newser
News impact scoring models applied to Larimar Therapeutics Inc.Trade Entry Report & High Conviction Trade Alerts - Newser
Is Larimar Therapeutics Inc. benefiting from innovation trendsJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - khodrobank.com
Will Larimar Therapeutics Inc. stock recover after earningsMarket Performance Report & High Conviction Buy Zone Alerts - khodrobank.com
Can machine learning forecast Larimar Therapeutics Inc. recoveryInsider Selling & Free Daily Entry Point Trade Alerts - Newser
Is Larimar Therapeutics Inc. backed by strong institutional buying2025 Analyst Calls & Risk Managed Investment Entry Signals - khodrobank.com
How hedge fund analytics apply to Larimar Therapeutics Inc. stockTrade Exit Summary & Risk Controlled Stock Alerts - Newser
Chart overlay techniques for tracking Larimar Therapeutics Inc.Market Performance Summary & Stepwise Entry/Exit Trade Alerts - Newser
Larimar Therapeutics Inc.’s volatility index tracking explained2025 Winners & Losers & Growth Focused Stock Pick Reports - Newser
Using fundamentals and technicals on Larimar Therapeutics Inc.Jobs Report & Weekly Breakout Opportunity Watchlist - Newser
Can a trend reversal in Larimar Therapeutics Inc. lead to recoveryWeekly Stock Analysis & Daily Entry Point Trade Alerts - Newser
What analysts say about Larimar Therapeutics Inc. stockJuly 2025 Outlook & Risk Adjusted Buy/Sell Alerts - khodrobank.com
Published on: 2025-09-03 05:33:18 - Newser
Using data tools to time your Larimar Therapeutics Inc. exit2025 Fundamental Recap & Free Community Consensus Stock Picks - Newser
Is Larimar Therapeutics Inc. still worth holding after the dipJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - Newser
Analyzing recovery setups for Larimar Therapeutics Inc. investorsPortfolio Risk Summary & Daily Entry Point Alerts - Newser
Should you wait for a breakout in Larimar Therapeutics Inc.2025 Fundamental Recap & Free Community Consensus Stock Picks - Newser
Will Larimar Therapeutics Inc. stock recover after recent dropJuly 2025 PreEarnings & Consistent Profit Trading Strategies - Newser
Is Larimar Therapeutics Inc. forming a reversal patternJuly 2025 Short Interest & Weekly Top Performers Watchlists - Newser
Does Larimar Therapeutics Inc. have strong EBITDA marginsProfit Target & Step-by-Step Swing Trade Plans - khodrobank.com
Earnings visualization tools for Larimar Therapeutics Inc.Earnings Summary Report & Detailed Earnings Play Alerts - Newser
Applying Wyckoff theory to Larimar Therapeutics Inc. stock2025 Bull vs Bear & AI Forecasted Stock Moves - Newser
Is Larimar Therapeutics Inc. stock bottoming outWeekly Trade Analysis & Verified Momentum Watchlists - Newser
Is Larimar Therapeutics Inc.’s ROE strong enoughJuly 2025 Weekly Recap & Weekly Watchlist of Top Performers - khodrobank.com
What’s the RSI of Larimar Therapeutics Inc. stockJuly 2025 Volume & Weekly High Return Stock Forecasts - khodrobank.com
What are Larimar Therapeutics Inc.’s recent SEC filings showingWeekly Trading Summary & Expert Approved Trade Ideas - khodrobank.com
Using R and stats models for Larimar Therapeutics Inc. forecastingWeekly Profit Report & Community Verified Trade Signals - Newser
Is Larimar Therapeutics Inc. in a consolidation phase2025 Technical Overview & AI Powered Trade Plan Recommendations - khodrobank.com
Is Larimar Therapeutics Inc. stock a good pick for beginners2025 Growth vs Value & Accurate Intraday Trading Signals - khodrobank.com
What are Larimar Therapeutics Inc.’s growth leversJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - khodrobank.com
Published on: 2025-09-01 11:18:16 - Newser
Larimar Therapeutics price target lowered to $18 from $22 at Citizens JMP - MSN
Larimar Therapeutics’ SWOT analysis: nomlabofusp’s potential reshapes FA stock outlook - Investing.com
Larimar Therapeutics Inc. Price Targets Raised After Rebound getLinesFromResByArray error: size == 0 - 강소기업뉴스
Larimar Therapeutics Advances Nomlabofusp Program Toward 2026 FDA Filing - MSN
Order flow analysis tools used on Larimar Therapeutics Inc.Earnings Trend Report & Capital Efficient Trade Techniques - Newser
Analysts Apply Wyckoff Model to Larimar Therapeutics Inc. Stock getLinesFromResByArray error: size == 0 - news-j.co.kr
Can Larimar Therapeutics Inc. Regain Momentum After BreakdownJuly 2025 Drop Watch & AI Powered Buy/Sell Recommendations - beatles.ru
Larimar Therapeutics Inc Stock (LRMR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):